Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGFβ receptor-JNK1 signalling

Evgeniy Panzhinskiy1, W Michael Zawada, Kurt R Stenmark

  • 1Department of Pharmaceutical Sciences, University of Wyoming, Laramie, WY, USA.

Insights

Hypoxia-induced pulmonary hypertension (PH) involves increased pulmonary artery fibroblast proliferation. The platelet-derived growth factor β receptor (PDGFβ-R) and c-Jun N-terminal kinase 1 (JNK1) pathway drives this proliferation, offering a potential therapeutic target for PH.

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Pulmonary hypertension (PH) is a proliferative vascular disease with no current disease-modifying therapies.
  • Adventitial fibroblasts in the pulmonary artery (PA) wall show increased replication in hypoxia-induced PH models.
  • Elevated platelet-derived growth factor β receptor (PDGFβ-R) signaling is implicated in PH pathogenesis.

Purpose of the Study:

  • To investigate the role of PDGFβ-R activation in fibroblast proliferation and adventitial remodeling in PH.
  • To test the hypothesis that PDGFβ-R signaling contributes to the cellular changes observed in PH.

Main Methods:

  • Newborn calves were exposed to high altitude to induce PH.
  • Measured PDGFβ-R phosphorylation in PA adventitia and cultured fibroblasts.
  • Utilized PDGF-BB stimulation and pharmacological/siRNA inhibition of JNK1 to assess proliferation.

Main Results:

  • Hypoxia-induced PH calves exhibited elevated PDGFβ-R phosphorylation in PA adventitia and fibroblasts.
  • PDGF-BB stimulation increased proliferation in PH fibroblasts, dependent on reactive oxygen species and ERK1/2.
  • PDGFβ-R-mediated proliferation in PH cells uniquely required c-Jun N-terminal kinase 1 (JNK1) activation.

Conclusions:

  • Hypoxia-induced changes in pulmonary artery cells involve the PDGFβ-R-JNK1 axis.
  • This axis confers heightened fibroblast proliferation and adventitial remodeling in PH.
  • Targeting the PDGFβ-R-JNK1 pathway may offer a novel therapeutic strategy for PH.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...